Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis

Clinical trial NCT00097331 · COMPLETED

Trial details

NCT number: NCT00097331
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2004-09-01
Primary completion: 2006-07-01
Enrollment: 261

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.